在患有吞困难的患者服用口服抗质药的替代方案
E Tejedor Tejada1, S Gonzalez Suárez1, T Lizondo López1
1Hospital Clínic Barcelona, Barcelona, Spain.
Journal of chemotherapy (Florence, Italy)
|May 20, 2024
概括
口腔癌药物对患有吞困难的患者来说可能具有挑战性. 本次审查更新了这些危险药物的安全处理和管理指南,以确保治疗的有效性和医疗保健工作人员的安全.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 患者安全 患者安全
背景情况:
- 瘤学患者经常出现吞障碍 (吞困难),影响治疗的坚持和疗效.
- 处理危险的口服抗瘤药物会给医疗保健专业人员 (包括护士和药剂师) 带来暴露的风险.
- 新型瘤药物的持续开发需要定期更新处理和施用协议.
研究的目的:
- 分析和更新关于在患有吞困难的瘤学患者中操纵口服抗瘤药物的建议.
- 为医疗保健专业人员和治疗口服化疗的患者提供当前咨询工具.
主要方法:
- 进行了全面的文献审查,包括文章,网站和关于处理和使用口服抗瘤剂的指导方针.
- 数据被编制成一个表格,详细介绍了110个活性成分,按药名,服用途径 (口服和鼻胃管) 和推做法进行分类.
- 信息进行了批判性评估,以确保其与当前临床实践的相关性和适用性.
主要成果:
- 大部分经过审查的口服抗瘤药物 (66.4%) 适合溶解.
- 汇编的数据为广泛的口服化疗药物提供了具体的管理指南.
- 该审查强调了由于癌症治疗方法的快速发展,需要不断更新信息.
结论:
- 更新的建议对于在患有食障碍的患者中安全有效地使用口服抗瘤药物的管理至关重要.
- 此更新的资源支持医疗保健提供者和患者在处理口服化疗的复杂性.
- 确保适当的处理和管理优化了治疗结果,并最大限度地降低了职业暴露风险.
相关概念视频
Drug Delivery: Enteral Route
420
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
420
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
197
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
197
Routes of Drug Administration: Enteral
3.5K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
3.5K
Enteral Nutrition I: Orogastric and Nasogastric Feeding
249
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
249
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
113
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
113
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
262
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
262


